 Dupont Capital Management Corp purchased a new stake in Albireo Pharma Inc NASDAQ:ALBO in the 2nd quarter, according to its most recent filing with the Securities Exchange Commission. The fund purchased 8,966 shares of the biopharmaceutical companys stock, valued at approximately 238,000. Dupont Capital Management Corp owned approximately 0.06 of Albireo Pharma as of ... 